269 related articles for article (PubMed ID: 25730373)
1. Dipeptidyl peptidase-4 deficiency protects against experimental diabetic nephropathy partly by blocking the advanced glycation end products-receptor axis.
Matsui T; Nakashima S; Nishino Y; Ojima A; Nakamura N; Arima K; Fukami K; Okuda S; Yamagishi S
Lab Invest; 2015 May; 95(5):525-33. PubMed ID: 25730373
[TBL] [Abstract][Full Text] [Related]
2. Linagliptin blocks renal damage in type 1 diabetic rats by suppressing advanced glycation end products-receptor axis.
Nakashima S; Matsui T; Takeuchi M; Yamagishi SI
Horm Metab Res; 2014 Sep; 46(10):717-21. PubMed ID: 24710699
[TBL] [Abstract][Full Text] [Related]
3. Advanced glycation end products evoke inflammatory reactions in proximal tubular cells via autocrine production of dipeptidyl peptidase-4.
Kaifu K; Ueda S; Nakamura N; Matsui T; Yamada-Obara N; Ando R; Kaida Y; Nakata M; Matsukuma-Toyonaga M; Higashimoto Y; Fukami K; Suzuki Y; Okuda S; Yamagishi SI
Microvasc Res; 2018 Nov; 120():90-93. PubMed ID: 30056058
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation end products evoke endothelial cell damage by stimulating soluble dipeptidyl peptidase-4 production and its interaction with mannose 6-phosphate/insulin-like growth factor II receptor.
Ishibashi Y; Matsui T; Maeda S; Higashimoto Y; Yamagishi S
Cardiovasc Diabetol; 2013 Aug; 12():125. PubMed ID: 23984879
[TBL] [Abstract][Full Text] [Related]
5. Dipeptidyl peptidase IV inhibitor attenuates kidney injury in streptozotocin-induced diabetic rats.
Liu WJ; Xie SH; Liu YN; Kim W; Jin HY; Park SK; Shao YM; Park TS
J Pharmacol Exp Ther; 2012 Feb; 340(2):248-55. PubMed ID: 22025647
[TBL] [Abstract][Full Text] [Related]
6. RAGE-Aptamer Blocks the Development and Progression of Experimental Diabetic Nephropathy.
Matsui T; Higashimoto Y; Nishino Y; Nakamura N; Fukami K; Yamagishi SI
Diabetes; 2017 Jun; 66(6):1683-1695. PubMed ID: 28385802
[TBL] [Abstract][Full Text] [Related]
7. DNA aptamer raised against receptor for advanced glycation end products suppresses renal tubular damage and improves insulin resistance in diabetic mice.
Sotokawauchi A; Matsui T; Higashimoto Y; Nishino Y; Koga Y; Yagi M; Yamagishi SI
Diab Vasc Dis Res; 2021; 18(1):1479164121990533. PubMed ID: 33535822
[TBL] [Abstract][Full Text] [Related]
8. Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.
Hou B; Qiang G; Zhao Y; Yang X; Chen X; Yan Y; Wang X; Liu C; Zhang L; Du G
Cell Physiol Biochem; 2017; 44(6):2378-2394. PubMed ID: 29262395
[TBL] [Abstract][Full Text] [Related]
9. Empagliflozin, an Inhibitor of Sodium-Glucose Cotransporter 2 Exerts Anti-Inflammatory and Antifibrotic Effects on Experimental Diabetic Nephropathy Partly by Suppressing AGEs-Receptor Axis.
Ojima A; Matsui T; Nishino Y; Nakamura N; Yamagishi S
Horm Metab Res; 2015 Aug; 47(9):686-92. PubMed ID: 25611208
[TBL] [Abstract][Full Text] [Related]
10. The dipeptidyl peptidase inhibitor linagliptin and the angiotensin II receptor blocker telmisartan show renal benefit by different pathways in rats with 5/6 nephrectomy.
Tsuprykov O; Ando R; Reichetzeder C; von Websky K; Antonenko V; Sharkovska Y; Chaykovska L; Rahnenführer J; Hasan AA; Tammen H; Alter M; Klein T; Ueda S; Yamagishi SI; Okuda S; Hocher B
Kidney Int; 2016 May; 89(5):1049-1061. PubMed ID: 27083282
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications.
Yamagishi S; Fukami K; Matsui T
Cardiovasc Diabetol; 2015 Jan; 14():2. PubMed ID: 25582643
[TBL] [Abstract][Full Text] [Related]
12. Stromal cell-derived factor-1 is upregulated by dipeptidyl peptidase-4 inhibition and has protective roles in progressive diabetic nephropathy.
Takashima S; Fujita H; Fujishima H; Shimizu T; Sato T; Morii T; Tsukiyama K; Narita T; Takahashi T; Drucker DJ; Seino Y; Yamada Y
Kidney Int; 2016 Oct; 90(4):783-96. PubMed ID: 27475229
[TBL] [Abstract][Full Text] [Related]
13. Swertiamarin mitigates nephropathy in high-fat diet/streptozotocin-induced diabetic rats by inhibiting the formation of advanced glycation end products.
Parwani K; Patel F; Bhagwat P; Dilip H; Patel D; Thiruvenkatam V; Mandal P
Arch Physiol Biochem; 2024 Apr; 130(2):136-154. PubMed ID: 34657540
[TBL] [Abstract][Full Text] [Related]
14. AGE-RAGE axis blockade in diabetic nephropathy: Current status and future directions.
Sanajou D; Ghorbani Haghjo A; Argani H; Aslani S
Eur J Pharmacol; 2018 Aug; 833():158-164. PubMed ID: 29883668
[TBL] [Abstract][Full Text] [Related]
15. Abelmoschus esculentus subfractions improved nephropathy with regulating dipeptidyl peptidase-4 and type 1 glucagon-like peptide receptor in type 2 diabetic rats.
Peng CH; Lin HC; Lin CL; Wang CJ; Huang CN
J Food Drug Anal; 2019 Jan; 27(1):135-144. PubMed ID: 30648566
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression.
Ojima A; Ishibashi Y; Matsui T; Maeda S; Nishino Y; Takeuchi M; Fukami K; Yamagishi S
Am J Pathol; 2013 Jan; 182(1):132-41. PubMed ID: 23159951
[TBL] [Abstract][Full Text] [Related]
17. Advanced glycation end products, oxidative stress and diabetic nephropathy.
Yamagishi S; Matsui T
Oxid Med Cell Longev; 2010; 3(2):101-8. PubMed ID: 20716934
[TBL] [Abstract][Full Text] [Related]
18. Deletion of the formin Diaph1 protects from structural and functional abnormalities in the murine diabetic kidney.
Manigrasso MB; Friedman RA; Ramasamy R; D'Agati V; Schmidt AM
Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1601-F1612. PubMed ID: 30132346
[TBL] [Abstract][Full Text] [Related]
19. Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor.
Sourris KC; Morley AL; Koitka A; Samuel P; Coughlan MT; Penfold SA; Thomas MC; Bierhaus A; Nawroth PP; Yamamoto H; Allen TJ; Walther T; Hussain T; Cooper ME; Forbes JM
Diabetologia; 2010 Nov; 53(11):2442-51. PubMed ID: 20631980
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of diabetic kidney injury in DPP4-deficient rats; role of GLP-1 on the suppression of AGE formation by inducing glyoxalase 1.
Sarker MK; Lee JH; Lee DH; Chun KH; Jun HS
Aging (Albany NY); 2020 Jan; 12(1):593-610. PubMed ID: 31905169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
